Inactivated vaccine for Ebola virus efficacious in guineapig model.
about
Current ebola vaccinesEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbolavirus vaccines for humans and apesEbola virus vaccines: an overview of current approachesMouse models for filovirus infectionsEbola and Marburg virus vaccines.Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virusEbola Vaccine: How Far are we?Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Advances in virus-like particle vaccines for filoviruses.Towards a vaccine against Ebola virus.Evaluation in nonhuman primates of vaccines against Ebola virus.Utility of Oral Swab Sampling for Ebola Virus Detection in Guinea Pig ModelGeneration and characterization of protective antibodies to Marburg virus.Replication-deficient ebolavirus as a vaccine candidate.Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.Return of inactivated whole-virus vaccine for superior efficacy.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Retracted: Ebola virus: an introduction and its pathology.Ebola vaccines in clinical trial: The promising candidates.Vaccines against 'the other' Ebolavirus species.Updates on Treatment of Ebola Virus Disease.Virus-Vectored Ebola Vaccines.Ebola takes a punch.Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
P2860
Q21534720-F442538E-073A-4953-B96D-15ED0AD29B1EQ24597625-0FF96CD0-0DD0-4D1E-9913-54CB56D5B3E7Q24631696-1E919A66-F40C-466E-8DE7-90070B4BC17CQ26999232-06684187-0578-4950-A632-B3904135C8EEQ27011569-F790E9BD-E3ED-4D77-9985-F72CC26B9273Q30234637-503D0104-68BF-4358-BF2D-528C706DBED5Q33417197-3640004B-2793-4882-B66A-3C5A70ACAD4CQ33831877-C6B432BF-4B03-4E91-90E8-8DA99295C905Q34551305-8B25D17A-61F9-4B94-BE3D-06309631704DQ34971349-75E24159-B331-44AE-8148-340D41CF22BAQ35300029-11376C7B-C4A2-4FA5-86D2-D40B453E9B35Q35623381-FD086A8A-2406-4713-ACF0-9C6255F16B2FQ36015461-41F6F76F-E89F-458D-B822-955B269CB25EQ36121626-CC2A01B4-3DEB-4796-A241-490232314225Q36305916-CC80EFB5-BA3B-4068-8A89-93465817D386Q37145203-4FCA530D-4211-46D6-8816-24F123488BFAQ37713766-3DB3336C-E9DF-4ECD-B2CC-845348ED66B0Q37918307-6416311E-E0C6-478F-984A-72574E550BD6Q37976671-CB5E3F47-0454-4C3F-87B4-893028A989E8Q38630575-93CE71BB-DE70-4460-A743-F927AF2A6D13Q38808678-70574D4B-5B2D-4B89-99D2-E506C810C40DQ40112699-95C4CD96-F835-46A8-B659-FCC7894C29B1Q40133255-0E9A5016-AD4D-4BDF-BB0C-1016834EDE36Q43284379-9F2912F0-EA11-4681-B23E-EE1D1B605A9CQ44089525-12804530-2136-487C-B087-FE8B7BCE8D1CQ47551100-EDD6290D-535F-475B-AA88-58CFC4D99E45Q56535662-1D4F9CDD-C37D-4D23-BC8A-C185DD5370F0
P2860
Inactivated vaccine for Ebola virus efficacious in guineapig model.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@en
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@nl
type
label
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@en
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@nl
prefLabel
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@en
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@nl
P2093
P921
P1433
P1476
Inactivated vaccine for Ebola virus efficacious in guineapig model.
@en
P2093
D L Bumgardner
H W Lupton
R D Lambert
P304
P356
10.1016/S0140-6736(80)92352-1
P407
P577
1980-12-01T00:00:00Z